| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
710 |
698 |
$70K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
431 |
414 |
$54K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
595 |
551 |
$43K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
478 |
433 |
$22K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
370 |
343 |
$21K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
446 |
419 |
$17K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
557 |
513 |
$16K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
169 |
161 |
$6K |
| 99205 |
Prolong outpt/office vis |
19 |
19 |
$3K |
| 87400 |
|
252 |
124 |
$2K |
| 87428 |
|
39 |
39 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
97 |
62 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
161 |
156 |
$336.14 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
27 |
27 |
$257.66 |
| 87503 |
|
12 |
12 |
$0.00 |